does tirzepatide cause osteoporosis Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Does GLP-1 Affect Bone Density?

Weight regain after stopping weight loss medication is common, particularly if the underlying lifestyle changes have not been sustained, which is why these medicines are intended as part of a broader long-term weight management programme

FDA Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (April 2026) Mentioned in This Article: Sermorelin When included as part of a comprehensive weight loss plan, sermorelin can help improve body composition, break down stored fat, and avoid the loss of muscle mass, which can be a detrimental effect of weight loss programs

Experts say a less expensive version of these GLP-1 medications would give more people access to these effective weight-loss drugs

10.1093/jnci/91.3.252 59 HongS.TianH.LuY.LabordeJ